The private label CBD gummies market is poised for significant growth, with projections indicating a rise from $598.9 million in 2025 to $1,382.2 million by 2036, according to a report by Future Market Insights (FMI). The market is expected to expand at a compound annual growth rate (CAGR) of 7.9% from 2026 to 2036. This growth is fueled by an increasing preference among wellness brands for outsourced manufacturing, rising demand for ready-to-market CBD edible products, and the adoption of white label production models that reduce launch costs and shorten commercialization timelines.
As competition intensifies across the functional wellness industry, companies are increasingly choosing private label CBD gummies to enter the market without investing in extraction facilities or confectionery manufacturing infrastructure. Retailers and regulators are placing greater emphasis on batch testing, ingredient traceability, labeling accuracy, and compliance documentation, encouraging manufacturers to strengthen quality assurance and transparency throughout the supply chain. White label gummies are projected to dominate the market by service model, accounting for 46.2% of global demand in 2026, due to shorter commercialization timelines and lower formulation costs.
Broad-spectrum CBD gummies are expected to capture 42.8% of market demand in 2026, supported by consumer preference for THC-free wellness products while retaining multiple naturally occurring cannabinoids. Brand websites remain the leading sales channel, representing 39.6% of global demand in 2026, as direct-to-consumer platforms allow brands to control customer education, product positioning, and subscription programs. The United States is projected to be the fastest-growing market, with a CAGR of 8.5% through 2036, driven by a strong direct-to-consumer infrastructure and a broad availability of private label manufacturing services.
Key players in the market include CBD Nationwide, Extract Labs, cbdMD, Inc., Charlotte's Web Holdings, Inc., CV Sciences, Inc., Medterra CBD LLC, British Cannabis, Cannaray Limited, MediPharm Labs Corp., and Little Green Pharma Ltd. These companies compete on formulation expertise, manufacturing scalability, compliance support, and packaging capabilities. For detailed market forecasts and competitive benchmarking, visit Future Market Insights.
